» Articles » PMID: 23271425

Major Trends in the Manifestations and Treatment of Rheumatoid Arthritis in a Multiethnic Cohort in Singapore

Abstract

We analyzed the epidemiological changes of rheumatoid arthritis (RA) over three decades using patients from a single center in Singapore. All patients who fulfill the 1987 American College of Rheumatology criteria for RA were invited to enroll in a prospective disease registry. We analyzed the patient demographics, disease manifestation, management and patient-reported outcomes, including quality of life (QoL), in the three categories according to the year of disease onset: before 1989 (group I), 1990-1999 (group II) and after 2000 (group III). There were 1,153 patients with 231, 532 and 390 in groups I, II and III, respectively. The mean disease durations were 25, 12 and 4.8 years, respectively. The majority was female (84.1 %) and Chinese (76.6 %) with no socio-demographic differences across the three periods. The age of onset rises and the prevalence of rheumatoid factor falls with the proximity of disease onset. Patients with most recent disease onset had the earliest access to the rheumatologist. They also had the highest tender and swollen joint counts, lowest deformed joint count and highest remission rate. Patients in group I report better mental and emotional QoL though many developed marked disability. We have documented changes of the manifestations of RA that are dependent and independent of improved treatment. Significant differences in accessibility to the rheumatologist, RA activity, functional capacity, quality of life and comorbidities were seen in subsequent cohorts due to treatment evolution and more efficient healthcare delivery.

Citing Articles

Haptoglobin 2-2 genotype is associated with increased risk of cardiovascular disease in patients with rheumatoid arthritis: a matched case-control study.

Xu C, Khin L, Tam H, Goh L, Koh E, Dalan R Front Med (Lausanne). 2025; 11:1442858.

PMID: 39741512 PMC: 11685008. DOI: 10.3389/fmed.2024.1442858.


Functional coding haplotypes and machine-learning feature elimination identifies predictors of Methotrexate Response in Rheumatoid Arthritis patients.

Lim A, Lim L, Ooi B, Koh E, Tan J, Chong S EBioMedicine. 2022; 75:103800.

PMID: 35022146 PMC: 8808170. DOI: 10.1016/j.ebiom.2021.103800.


The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort.

Xu C, Yong M, Koh E, Dalan R, Leong K Rheumatol Adv Pract. 2021; 5(3):rkab077.

PMID: 34778702 PMC: 8578689. DOI: 10.1093/rap/rkab077.


Conversion among the 28-joint count activity indices for rheumatoid arthritis.

Leong K, Tan J, Gao X, Koh E Eur J Rheumatol. 2020; 7(3):105-111.

PMID: 32809931 PMC: 7431355. DOI: 10.5152/eurjrheum.2020.19199.


Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.

Chai G, Tan T, Lee Y, Kaw G, Chuah K, Lim Y Singapore Med J. 2019; 61(6):302-307.

PMID: 31317200 PMC: 7905130. DOI: 10.11622/smedj.2019069.


References
1.
Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R . Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003; 62(9):897-900. PMC: 1754657. DOI: 10.1136/ard.62.9.897. View

2.
Jamal S, Alibhai S, Badley E, Bombardier C . Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol. 2011; 38(7):1282-8. DOI: 10.3899/jrheum.101315. View

3.
Cimmino M, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia M . Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int. 2000; 19(6):213-7. DOI: 10.1007/pl00006853. View

4.
Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen S, Hetland M . QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007; 66(11):1491-6. PMC: 2111618. DOI: 10.1136/ard.2006.069252. View

5.
Turesson C, OFallon W, Crowson C, Gabriel S, Matteson E . Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003; 62(8):722-7. PMC: 1754626. DOI: 10.1136/ard.62.8.722. View